| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/26/2012 | CN102154220B Method and equipment for ultrahigh-density and large-scale production of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 12/26/2012 | CN102085366B Compound vaccine adjuvant |
| 12/26/2012 | CN102058882B Method of preparing hepatitis A inactivated vaccine |
| 12/26/2012 | CN101948792B O157:H7 enhancement mucosal immunity multivalence fusion type recombination strain and vaccine |
| 12/26/2012 | CN101829154B Preparation method of medicine composition for preventing and treating asthma |
| 12/26/2012 | CN101568550B Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 12/26/2012 | CN101513526B Application of combined vaccine in treating tumors |
| 12/26/2012 | CN101460520B Hepatocyte growth factor (hgf) binding proteins |
| 12/26/2012 | CN101372511B Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 12/26/2012 | CN101210051B Anti-VEGF antibodies |
| 12/26/2012 | CN101139392B KDR peptides and vaccines containing the same |
| 12/26/2012 | CN101072587B Anti-cd154 antibodies |
| 12/26/2012 | CN101048425B KID3 and KID3 antibodies that bind thereto |
| 12/25/2012 | US8338582 Anti-HIV immunogens and methods for inducing an immune response |
| 12/25/2012 | US8338576 Antibodies specific for DKK-1 and their uses |
| 12/25/2012 | US8338574 FC variants with altered binding to FCRN |
| 12/25/2012 | US8338379 Monoclonal antibody and use thereof |
| 12/25/2012 | US8338159 Chicken virus vaccine and diagnostic |
| 12/25/2012 | US8338156 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| 12/25/2012 | US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 12/25/2012 | US8338137 Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strains |
| 12/25/2012 | US8338089 Inhibiting lentivirus which expresses Viral Infectivity Factor (VIF) protein; membrane-permeable zinc chelator is N,N,N',N'-Tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN); kits |
| 12/25/2012 | US8337866 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 12/25/2012 | US8337865 Modified flagellin improved toll-like receptor 5 stimulating activity |
| 12/25/2012 | US8337864 Modified flagellin improved toll-like receptor 5 stimulating activity |
| 12/25/2012 | US8337863 Anti-sepsis conjugate vaccine |
| 12/25/2012 | US8337862 Method for treating knee joint pain caused by saphenous nerve entrapment |
| 12/25/2012 | US8337861 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 12/25/2012 | US8337860 Development of dengue virus vaccine components |
| 12/25/2012 | US8337859 Vectors for multiple gene expression |
| 12/25/2012 | US8337857 Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection |
| 12/25/2012 | US8337856 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 12/25/2012 | US8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 12/25/2012 | US8337854 Monoclonal antibodies against dengue and other viruses with deletion in Fc region |
| 12/25/2012 | US8337853 Monoclonal antibodies that bind or neutralize dengue virus |
| 12/25/2012 | US8337852 Anti-C5aR antibodies with improved properties |
| 12/25/2012 | US8337851 Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer |
| 12/25/2012 | US8337850 4-1BB binding molecules |
| 12/25/2012 | US8337849 Anti-IL6/IL-6R antibodies |
| 12/25/2012 | US8337848 Monoclonal antibody for APP |
| 12/25/2012 | US8337847 Methods of treating anemia using anti-IL-6 antibodies |
| 12/25/2012 | US8337846 Immunogenic polypeptides and monoclonal antibodies |
| 12/25/2012 | US8337845 A-beta binding polypeptides |
| 12/25/2012 | US8337844 CD20-binding polypeptide compositions for treating autoimmune disease |
| 12/25/2012 | US8337843 Treatment of metastatic breast cancer |
| 12/25/2012 | US8337842 Monoclonal antibodies |
| 12/25/2012 | US8337841 Methods of screening for antibody light chains |
| 12/25/2012 | US8337840 Anti-CD19 antibodies |
| 12/25/2012 | US8337839 High affinity human antibodies to human IL-4 receptor |
| 12/25/2012 | US8337838 Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 12/25/2012 | US8337836 Methods for the treatment and prevention of diseases of biological conduits |
| 12/25/2012 | US8337832 Vaccine for protection against Shigella sonnei disease |
| 12/25/2012 | US8337830 Yeast-based vaccines as immunotherapy |
| 12/20/2012 | WO2012174455A2 Group a streptococcus multivalent vaccine |
| 12/20/2012 | WO2012174446A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer |
| 12/20/2012 | WO2012174338A2 Method of selecting therapeutic indications |
| 12/20/2012 | WO2012174327A1 Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab |
| 12/20/2012 | WO2012174280A2 Methods and compositions for modulating myofibroblast activities |
| 12/20/2012 | WO2012174220A1 Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection |
| 12/20/2012 | WO2012174178A1 Anti-angptl3 antibodies and uses thereof |
| 12/20/2012 | WO2012174160A1 Tem8 antibodies, conjugates thereof, and their use |
| 12/20/2012 | WO2012174055A1 Wound healing using complement inhibitors |
| 12/20/2012 | WO2012173867A1 Dosage and administration of anti-erbb3 antibodies in combination with tyrosine kinase inhibitors |
| 12/20/2012 | WO2012173819A2 Anti-cd3 therapies |
| 12/20/2012 | WO2012173781A2 Methods of treating glucose metabolism disorders |
| 12/20/2012 | WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals |
| 12/20/2012 | WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes |
| 12/20/2012 | WO2012172574A1 Vaccine composition comprising an inactivated chikungunya virus strain |
| 12/20/2012 | WO2012172555A1 Combination therapy to prevent dcis formation and progression to breast cancer |
| 12/20/2012 | WO2012172102A1 Selective elimination of erosive cells |
| 12/20/2012 | WO2012172070A1 Tumour necrosis factor receptor 1 antagonists |
| 12/20/2012 | WO2012172042A1 Vaccines for chlamydia |
| 12/20/2012 | WO2012172037A1 A method for the production of hydrolyzed allergens |
| 12/20/2012 | WO2012171104A1 Rabies virus like particle production in plants |
| 12/20/2012 | WO2012171077A1 Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage |
| 12/20/2012 | WO2012171057A1 Antibodies against g-csfr and uses thereof |
| 12/20/2012 | WO2012149404A3 Liquid vaccine preparations |
| 12/20/2012 | WO2012144726A3 Tumor antigen proteins or genes of polo-like kinase 1 |
| 12/20/2012 | WO2012143375A3 Hypoallergens |
| 12/20/2012 | WO2012115437A3 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target |
| 12/20/2012 | WO2012102529A3 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit |
| 12/20/2012 | WO2012046061A3 Clostridium difficile antigens |
| 12/20/2012 | WO2012024659A9 Antibody-based constructs directed against tyrosine kinase receptors |
| 12/20/2012 | WO2011138040A8 Vaccine against beta-herpesvirus infection and use thereof |
| 12/20/2012 | WO2007012811A9 Prostate stem cell markers |
| 12/20/2012 | US20120323214 Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis |
| 12/20/2012 | US20120322975 Nucleic acids encoding antibodies that bind factor d |
| 12/20/2012 | US20120322672 Method for generating and selecting antibodies against target protein |
| 12/20/2012 | US20120322663 Dry glassy composition comprising a bioactive material |
| 12/20/2012 | US20120322105 Growth factor |
| 12/20/2012 | US20120321719 Sustained Delivery of Therapeutic Agents to an Eye Compartment |
| 12/20/2012 | US20120321699 Method of inducing the production of protective anti-hiv-1 antibodies |
| 12/20/2012 | US20120321694 Compositions and uses |
| 12/20/2012 | US20120321692 Methods and Dressings for Sealing Internal Injuries |
| 12/20/2012 | US20120321687 Compositions and methods for using and identifying antimicrobial agents |
| 12/20/2012 | US20120321678 Intra-articularly supplementation method for treating joint diseases and injuries |
| 12/20/2012 | US20120321676 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof |
| 12/20/2012 | US20120321672 Method of treating attention deficit hyperactivity disorder |
| 12/20/2012 | US20120321669 Antigenic compositions |
| 12/20/2012 | US20120321665 Compositions and methods for treating airway inflammatory diseases |